Paraganglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paraganglioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT Scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Paraganglioma secondary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paraganglioma secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paraganglioma secondary prevention

CDC on Paraganglioma secondary prevention

Paraganglioma secondary prevention in the news

Blogs on Paraganglioma secondary prevention

Directions to Hospitals Treating Paraganglioma

Risk calculators and risk factors for Paraganglioma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

## Overview[edit | edit source]

There are no established measures for the secondary prevention of [disease name].

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

## Secondary Prevention[edit | edit source]

There are no established measures for the secondary prevention of [disease name].

Effective measures for the secondary prevention of [disease name] include:

* [Strategy 1]
* [Strategy 2]
* [Strategy 3]

## References[edit | edit source]

Template:WH Template:WS